BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37755609)

  • 1. Anticoagulation in renal replacement therapies: Why heparin should be abandoned in critical ill patients?
    Musalem P; Pedreros-Rosales C; Müller-Ortiz H
    Int Urol Nephrol; 2024 Apr; 56(4):1383-1393. PubMed ID: 37755609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Zhou Z; Liu C; Yang Y; Wang F; Zhang L; Fu P
    Crit Care; 2023 Jun; 27(1):222. PubMed ID: 37287084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the application of regional citrate anticoagulation for continuous renal replacement therapy in patients with liver failure].
    Ning QQ; Meng QH; Zhu YK
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):549-552. PubMed ID: 30317782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials.
    Li R; Gao X; Zhou T; Li Y; Wang J; Zhang P
    Ther Apher Dial; 2022 Dec; 26(6):1086-1097. PubMed ID: 35385216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
    Arnold F; Westermann L; Rieg S; Neumann-Haefelin E; Biever PM; Walz G; Kalbhenn J; Tanriver Y
    BMC Nephrol; 2020 Nov; 21(1):486. PubMed ID: 33198670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.
    Fiaccadori E; Pistolesi V; Mariano F; Mancini E; Canepari G; Inguaggiato P; Pozzato M; Morabito S
    J Nephrol; 2015 Apr; 28(2):151-64. PubMed ID: 25585821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
    Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate anticoagulation in the ICU: the Leeds experience.
    Trumper C
    Br J Nurs; 2016 Sep; 25(16):902-6. PubMed ID: 27615524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.
    Kutsogiannis DJ; Gibney RT; Stollery D; Gao J
    Kidney Int; 2005 Jun; 67(6):2361-7. PubMed ID: 15882280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.